CTMX logo

CytomX Therapeutics, Inc.

CTMX
Healthcare|Biotechnology|US
$2.19
+0.05 (+2.34%)
Tangible Book / Share
$1.29
Cash / Share
$1.59

Ownership Breakdown

81.1%
Float
217.9M
Shares Outstanding
176.7M
Float Shares

Major Holders (40)

Combined: 240.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Abigail P. JohnsonIndividual14.60%24,688,109Feb 5, 202613D/G
FMR LLCHolding company14.60%24,688,109Feb 5, 202613D/G
BVF Partners L.P.IA, PN9.99%8,089,795Nov 14, 202413D/G
Mark N. LampertIndividual9.99%8,089,795Nov 14, 202413D/G
BVF Inc.Corporation9.99%8,089,795Nov 14, 202413D/G
Kynam Capital Management, LPInvestment adviser9.96%0Aug 14, 202613D/G
Kynam Capital Management GP, LLCOther9.96%0Aug 14, 202613D/G
Yue TangIndividual9.96%0Aug 14, 202613D/G
Bong Y KohIndividual8.20%12,992,500May 20, 202513D/G
BlackRock, Inc.Holding company7.60%16,551,452Jul 27, 202613D/G
Patrick G. EnrightIndividual7.00%15,288,461May 15, 202613D/G
Juliet Tammenoms BakkerIndividual7.00%15,288,461May 15, 202613D/G
Biotechnology Value Fund, L.P.Partnership7.00%5,655,929Nov 14, 202413D/G
Janus Henderson Biotech Innovation Master Fund LtdInvestment company6.20%4,809,518Nov 14, 202413D/G
Longitude Capital Partners V, LLCOther5.70%12,458,461May 15, 202613D/G
Longitude Venture Partners V, L.P.Partnership5.70%12,458,461May 15, 202613D/G
Bank of America Corp /De/Holding company5.40%11,867,012Oct 28, 202613D/G
State Street CorporationHolding company5.40%11,747,236Aug 7, 202613D/G
Perceptive Advisors LLCInvestment adviser4.60%10,098,824May 15, 202613D/G
VHCP Management EG, LLCOther4.60%9,982,124May 15, 202613D/G
VHCP Management III, LLCOther4.60%9,982,124May 15, 202613D/G
Venrock Healthcare Capital Partners EG, L.P.Partnership4.60%9,982,124May 15, 202613D/G
VHCP Co-Investment Holdings III, LLCOther4.60%9,982,124May 15, 202613D/G
Venrock Healthcare Capital Partners III, L.P.Partnership4.60%9,982,124May 15, 202613D/G
Perceptive Life Sciences Master Fund, Ltd.Corporation4.60%10,098,824May 15, 202613D/G
Joseph EdelmanIndividual4.60%10,098,824May 15, 202613D/G
Bong Y. KohIndividual4.60%9,982,124May 15, 202613D/G
Nimish ShahIndividual4.60%9,982,124May 15, 202613D/G
BVF I GP LLCOther3.80%6,148,026Jul 9, 202513D/G
Biotechnology Value Fund L PPartnership3.80%6,148,026Jul 9, 202513D/G
Steven A. CohenIndividual3.60%7,811,033Aug 14, 202613D/G
Point72 Asset Management, L.P.Partnership3.60%7,811,033Aug 14, 202613D/G
Point72 Capital Advisors, Inc.Corporation3.60%7,811,033Aug 14, 202613D/G
BVF Inc/IlCorporation3.50%5,769,231Jul 9, 202513D/G
BVF Partners L P/IlIA, PN3.50%5,769,231Jul 9, 202513D/G
Lampert Mark NIndividual3.50%5,769,231Jul 9, 202513D/G
BVF GP Holdings LLCOther3.30%5,425,459Jul 9, 202513D/G
Biotechnology Value Fund II LPPartnership2.90%4,702,892Jul 9, 202513D/G
Biotechnology Value Fund II, L.P.Partnership2.70%2,135,164Nov 14, 202413D/G
OrbiMed Advisors LLCInvestment adviser2.10%3,525,650Feb 17, 202613D/G

Insider Trades (100)

Last 4 quarters: 4,141,000 acquired · 294,480 disposed
InsiderPositionDateTypeSharesPriceValueFiling
McCarthy Sean A.director, officer: CEONov 6, 2025OPTION EX.101,793$1.59$161.9KForm 4
McCarthy Sean A.director, officer: CEONov 6, 2025SELL101,793$4.54$461.9KForm 4
McCarthy Sean A.director, officer: CEONov 6, 2025OPTION EX.101,793$1.59$161.9KForm 4
Carvajal AlejandraChief Legal OfficerAug 3, 2026AWARD450,000$3.17$1.4MForm 4
Carvajal AlejandraChief Legal OfficerAug 3, 2026AWARD100,000——Form 4
Carvajal AlejandraAug 3, 2026OTHER0——Form 4
Fuchs Charles S.directorJul 24, 2026AWARD118,000$3.24$382.3KForm 4
Fuchs Charles S.Jul 24, 2026OTHER0——Form 4
Su ZhendirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Young Matthew P.directorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Mohindru ManidirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Meyers James RdirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Gilbert Halley EdirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Ashworth AlandirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Jones Elaine VdirectorJun 17, 2026AWARD59,000$2.96$174.6KForm 4
Ogden ChristopherChief Financial OfficerJun 15, 2026SELL1,624$3.05$5.0KForm 4
Chu Yu-WayeChief Medical OfficerMar 17, 2026SELL21,279$6.42$136.7KForm 4
McCarthy Sean A.director, officer: CEOMar 17, 2026SELL118,969$6.42$764.1KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerMar 17, 2026SELL31,492$6.42$202.3KForm 4
Ogden ChristopherChief Financial OfficerMar 17, 2026SELL19,323$6.42$124.1KForm 4
Lester RachaelChief Business OfficerFeb 2, 2026AWARD50,000$6.09$304.5KForm 4
Lester RachaelChief Business OfficerFeb 2, 2026AWARD50,000——Form 4
Lester RachaelChief Business OfficerFeb 2, 2026AWARD20,000——Form 4
Chu Yu-WayeChief Medical OfficerFeb 2, 2026AWARD300,000$6.09$1.8MForm 4
Chu Yu-WayeChief Medical OfficerFeb 2, 2026AWARD75,000——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 2, 2026AWARD60,000——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 2, 2026AWARD250,000$6.09$1.5MForm 4
Ogden ChristopherChief Financial OfficerFeb 2, 2026AWARD325,000$6.09$2.0MForm 4
Ogden ChristopherChief Financial OfficerFeb 2, 2026AWARD90,000——Form 4
McCarthy Sean A.director, officer: CEOFeb 2, 2026AWARD210,000——Form 4
McCarthy Sean A.director, officer: CEOFeb 2, 2026AWARD980,000$6.09$6.0MForm 4
McCarthy Sean A.director, officer: CEONov 6, 2025SELL101,793$4.54$461.9KForm 4
Lester RachaelChief Business OfficerOct 20, 2025AWARD650,000$3.74$2.4MForm 4
Lester RachaelOct 20, 2025OTHER0——Form 4
McCarthy Sean A.director, officer: CEOSep 26, 2025AWARD570,000$2.90$1.7MForm 4
McCarthy Sean A.director, officer: CEOSep 26, 2025AWARD285,000——Form 4
Chu Yu-WayeChief Medical OfficerSep 26, 2025AWARD87,500$2.90$253.8KForm 4
Chu Yu-WayeChief Medical OfficerSep 26, 2025AWARD43,750——Form 4
Ogden ChristopherChief Financial OfficerSep 26, 2025AWARD78,250$2.90$226.9KForm 4
Ogden ChristopherChief Financial OfficerSep 26, 2025AWARD39,150——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerSep 26, 2025AWARD36,300$2.90$105.3KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerSep 26, 2025AWARD18,150——Form 4
Ogden ChristopherChief Financial OfficerJun 13, 2025OPTION EX.37,500——Form 4
Ogden ChristopherChief Financial OfficerJun 16, 2025SELL10,614$2.69$28.5KForm 4
Ogden ChristopherChief Financial OfficerJun 13, 2025SELL1,641$2.95$4.8KForm 4
Ogden ChristopherChief Financial OfficerJun 13, 2025OPTION EX.37,500——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerJun 13, 2025OPTION EX.37,500——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerJun 16, 2025SELL13,884$2.69$37.3KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerJun 13, 2025OPTION EX.37,500——Form 4
McCarthy Sean A.director, officer: CEOJun 13, 2025OPTION EX.150,000——Form 4
McCarthy Sean A.director, officer: CEOJun 16, 2025SELL55,511$2.69$149.3KForm 4
McCarthy Sean A.director, officer: CEOJun 13, 2025OPTION EX.150,000——Form 4
Su ZhendirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Young Matthew P.directorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Mohindru ManidirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Meyers James RdirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Jones Elaine VdirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Gilbert Halley EdirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
Ashworth AlandirectorJun 11, 2025AWARD38,000$2.82$107.2KForm 4
McCarthy Sean A.director, officer: CEOMar 18, 2025SELL37,656$0.60$22.6KForm 4
Ogden ChristopherChief Financial OfficerMar 18, 2025SELL8,551$0.60$5.1KForm 4
Chu Yu-WayeChief Medical OfficerMar 18, 2025SELL4,025$0.60$2.4KForm 4
ROWLAND LLOYD AGeneral CounselMar 18, 2025SELL10,203$0.60$6.1KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerMar 18, 2025SELL19,512$0.60$11.7KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD57,500——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD35,000——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD150,000$0.86$129.6KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD57,500——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD30,000——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD140,000$0.86$121.0KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerFeb 4, 2025AWARD115,000$0.86$99.4KForm 4
Chu Yu-WayeChief Medical OfficerFeb 4, 2025AWARD238,000$0.86$205.6KForm 4
Chu Yu-WayeChief Medical OfficerFeb 4, 2025AWARD57,500——Form 4
Chu Yu-WayeChief Medical OfficerFeb 4, 2025AWARD115,000$0.86$99.4KForm 4
Chu Yu-WayeChief Medical OfficerFeb 4, 2025AWARD56,000——Form 4
Ogden ChristopherChief Financial OfficerFeb 4, 2025AWARD225,000$0.86$194.4KForm 4
Ogden ChristopherChief Financial OfficerFeb 4, 2025AWARD57,500——Form 4
Ogden ChristopherChief Financial OfficerFeb 4, 2025AWARD44,000——Form 4
Ogden ChristopherChief Financial OfficerFeb 4, 2025AWARD115,000$0.86$99.4KForm 4
McCarthy Sean A.director, officer: CEOFeb 4, 2025AWARD195,000——Form 4
McCarthy Sean A.director, officer: CEOFeb 4, 2025AWARD180,000——Form 4
McCarthy Sean A.director, officer: CEOFeb 4, 2025AWARD800,000$0.86$691.2KForm 4
McCarthy Sean A.director, officer: CEOFeb 4, 2025AWARD390,000$0.86$337.0KForm 4
Landau Jeffrey BChief Business OfficerAug 20, 2024OPTION EX.11,250——Form 4
Landau Jeffrey BChief Business OfficerAug 20, 2024SELL4,181$1.23$5.1KForm 4
Landau Jeffrey BChief Business OfficerAug 20, 2024OPTION EX.11,250——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerAug 20, 2024OPTION EX.11,250——Form 4
BELVIN MARCIASVP, Chief Scientific OfficerAug 20, 2024SELL4,181$1.23$5.1KForm 4
BELVIN MARCIASVP, Chief Scientific OfficerAug 20, 2024OPTION EX.11,250——Form 4
ROWLAND LLOYD AGeneral CounselAug 20, 2024OPTION EX.11,250——Form 4
ROWLAND LLOYD AGeneral CounselAug 20, 2024SELL4,181$1.23$5.1KForm 4
ROWLAND LLOYD AGeneral CounselAug 20, 2024OPTION EX.11,250——Form 4
Ogden ChristopherChief Financial OfficerAug 20, 2024OPTION EX.6,875——Form 4
Ogden ChristopherChief Financial OfficerAug 20, 2024SELL1,984$1.23$2.4KForm 4
Ogden ChristopherChief Financial OfficerAug 20, 2024OPTION EX.6,875——Form 4
McCarthy Sean A.director, officer: CEOAug 20, 2024OPTION EX.37,500——Form 4
McCarthy Sean A.director, officer: CEOAug 20, 2024SELL13,898$1.23$17.1KForm 4
McCarthy Sean A.director, officer: CEOAug 20, 2024OPTION EX.37,500——Form 4
Ogden ChristopherChief Financial OfficerJun 12, 2024AWARD17,500——Form 4
Ogden ChristopherChief Financial OfficerJun 12, 2024AWARD75,000$1.49$111.8KForm 4